BridgeBio Pharma, Inc. - BBIO
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 17, 2026 | SCHEDULE 13D/A | — | 4.7% | — | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Farallon Capital Management, L.L.C. | 5.5% | 10,743,063 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Farallon Capital Partners, L.P. | 0.0% | 0 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Farallon Capital Institutional Partners, L.P. | 0.0% | 0 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Farallon Capital Institutional Partners II, L.P. | 0.0% | 0 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Farallon Capital Institutional Partners III, L.P. | 0.0% | 0 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Four Crossings Institutional Partners V, L.P. | 0.0% | 0 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Farallon Capital Offshore Investors II, L.P. | 0.0% | 0 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Farallon Capital (AM) Investors, L.P. | 0.0% | 0 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Farallon Capital F5 Master I, L.P. | 0.0% | 0 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Farallon Healthcare Partners Master, L.P. | 0.0% | 0 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Farallon Partners, L.L.C. | 0.0% | 0 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Farallon Institutional (GP) V, L.L.C. | 0.0% | 0 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Farallon F5 (GP), L.L.C. | 0.0% | 0 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Farallon Healthcare Partners (GP), L.L.C. | 0.0% | 0 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Dapice Joshua J. | 5.5% | 10,743,063 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Dreyfuss, Philip D. | 5.5% | 10,743,063 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Dunn Hannah E. | 5.5% | 10,743,063 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Gehani, Varun N. | 5.5% | 10,743,063 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Giauque, Nicolas | 5.5% | 10,743,063 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Husen, Avner A. | 5.5% | 10,743,063 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Kim, David T. | 5.5% | 10,743,063 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Linn, Michael G. | 5.5% | 10,743,063 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Luo Patrick (Cheng) | 5.5% | 10,743,063 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Roberts, Jr., Thomas G. | 5.5% | 10,743,063 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Saito Edric C. | 5.5% | 10,743,063 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Short Daniel S. | 5.5% | 10,743,063 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Spokes, Andrew J. M. | 5.5% | 10,743,063 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Warren, John R. | 5.5% | 10,743,063 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | Wehrly, Mark C. | 5.5% | 10,743,063 | View |
| Jul 27, 2026 | SCHEDULE 13G/A | BlackRock, Inc. | 4.96% | 9,733,762 | View |
| Jul 10, 2026 | SCHEDULE 13D/A | — | 5.0% | — | View |
| May 29, 2026 | SCHEDULE 13G | Farallon Capital Partners, L.P. | 0.4% | 728,238 | View |
| May 29, 2026 | SCHEDULE 13G | Farallon Capital Institutional Partners, L.P. | 0.5% | 922,612 | View |
| May 29, 2026 | SCHEDULE 13G | Farallon Capital Institutional Partners II, L.P. | 0.1% | 167,053 | View |
| May 29, 2026 | SCHEDULE 13G | Farallon Capital Institutional Partners III, L.P. | 0.1% | 145,089 | View |
| May 29, 2026 | SCHEDULE 13G | Four Crossings Institutional Partners V, L.P. | 0.1% | 171,156 | View |
| May 29, 2026 | SCHEDULE 13G | Farallon Capital Offshore Investors II, L.P. | 1.0% | 1,869,577 | View |
| May 29, 2026 | SCHEDULE 13G | Farallon Capital (AM) Investors, L.P. | 0.1% | 100,702 | View |
| May 29, 2026 | SCHEDULE 13G | Farallon Capital F5 Master I, L.P. | 0.1% | 202,722 | View |
| May 29, 2026 | SCHEDULE 13G | Farallon Healthcare Partners Master, L.P. | 3.0% | 5,918,914 | View |
| May 29, 2026 | SCHEDULE 13G | Farallon Partners, L.L.C. | 5.1% | 10,023,341 | View |
| May 29, 2026 | SCHEDULE 13G | Farallon Institutional (GP) V, L.L.C. | 0.1% | 171,156 | View |
| May 29, 2026 | SCHEDULE 13G | Farallon F5 (GP), L.L.C. | 0.1% | 202,722 | View |
| May 29, 2026 | SCHEDULE 13G | Farallon Healthcare Partners (GP), L.L.C. | 3.0% | 5,918,914 | View |
| May 29, 2026 | SCHEDULE 13G | Dapice Joshua J. | 5.2% | 10,226,063 | View |
| May 29, 2026 | SCHEDULE 13G | Dreyfuss, Philip D. | 5.2% | 10,226,063 | View |
| May 29, 2026 | SCHEDULE 13G | Dunn Hannah E. | 5.2% | 10,226,063 | View |
| May 29, 2026 | SCHEDULE 13G | Gehani, Varun N. | 5.2% | 10,226,063 | View |
| May 29, 2026 | SCHEDULE 13G | Giauque, Nicolas | 5.2% | 10,226,063 | View |
| May 29, 2026 | SCHEDULE 13G | Husen, Avner A. | 5.2% | 10,226,063 | View |
| May 29, 2026 | SCHEDULE 13G | Kim, David T. | 5.2% | 10,226,063 | View |
| May 29, 2026 | SCHEDULE 13G | Linn, Michael G. | 5.2% | 10,226,063 | View |
| May 29, 2026 | SCHEDULE 13G | Luo Patrick (Cheng) | 5.2% | 10,226,063 | View |
| May 29, 2026 | SCHEDULE 13G | Roberts, Jr., Thomas G. | 5.2% | 10,226,063 | View |
| May 29, 2026 | SCHEDULE 13G | Saito Edric C. | 5.2% | 10,226,063 | View |
| May 29, 2026 | SCHEDULE 13G | Short Daniel S. | 5.2% | 10,226,063 | View |
| May 29, 2026 | SCHEDULE 13G | Spokes, Andrew J. M. | 5.2% | 10,226,063 | View |
| May 29, 2026 | SCHEDULE 13G | Warren, John R. | 5.2% | 10,226,063 | View |
| May 29, 2026 | SCHEDULE 13G | Wehrly, Mark C. | 5.2% | 10,226,063 | View |
| May 15, 2026 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 6.8% | 13,179,013 | View |
| Apr 16, 2026 | SCHEDULE 13G/A | NEIL KUMAR | 4.6% | 9,282,982 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.